Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a newer patch level has been applied to the page metadata. It signals a minor update to the page's versioning metadata and change log rather than alterations to core content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s footer software revision was updated from **v3.5.2** to **v3.5.3** without any stated changes to the underlying study details.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check102 days agoChange DetectedRevision tag updated to v3.4.2 and the previous funding/status notice (v3.4.1) was removed. The core study details remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.